z-logo
open-access-imgOpen Access
Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains
Author(s) -
Chao Wang,
Weiguo Shi,
Lifeng Cai,
Lu Lu,
Fei Yu,
Qian Wang,
Xifeng Jiang,
Xiaoyu Xu,
Kun Wang,
Liang Xu,
Shibo Jiang,
Keliang Liu
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku010
Subject(s) - enfuvirtide , human immunodeficiency virus (hiv) , biology , virology , heptad repeat , peptide , chemistry , gp41 , biochemistry , peptide sequence , immunology , antibody , epitope , gene
To develop new HIV-1 fusion inhibitors with improved antiviral activities and resistance profiles, we designed two categories of artificial peptides, each containing four heptad repeats (m4HR) conjugated with a pocket-specific small molecule (pssm) or pssm and cholesterol (chol), designated pssm-m4HR or pssm-m4HR-chol, respectively, and tested their anti-HIV-1 activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom